ACADIAN ASSET MANAGEMENT LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 130 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,633
-50.7%
4,560,770
-7.7%
0.01%
-58.3%
Q1 2024$3,311
+28.4%
4,943,260
+4.0%
0.01%
+20.0%
Q4 2023$2,579
+47.1%
4,750,875
+62.3%
0.01%
+42.9%
Q3 2023$1,753
-52.2%
2,927,769
+3.7%
0.01%
-53.3%
Q2 2023$3,665
+345.9%
2,821,980
+502.7%
0.02%
+275.0%
Q1 2023$822
-99.3%
468,239
+4617.8%
0.00%
Q1 2021$124,000
+19.2%
9,925
+48.5%
0.00%
Q4 2020$104,000
-84.5%
6,685
-85.1%
0.00%
-100.0%
Q3 2017$673,00044,8620.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Alexandria Capital, LLC 968,505$12,135,0001.23%
Golden State Equity Partners 126,608$1,586,0000.90%
McGuire Investment Group, LLC 272,801$3,418,0000.72%
Lombard Odier Asset Management (Switzerland) SA 848,429$10,631,0000.70%
Rhenman & Partners Asset Management AB 765,000$9,585,0000.67%
EMC Capital Management 72,061$903,0000.64%
WASATCH ADVISORS LP 10,328,423$129,415,0000.58%
Ceeto Capital Group, LLC 74,000$927,0000.45%
Fort Sheridan Advisors LLC 75,945$952,0000.38%
Vanguard Capital Wealth Advisors 34,580$388,679,0000.33%
View complete list of SANGAMO THERAPEUTICS INC shareholders